文献速递慢性肾脏病血液净化与透析

慢性肾脏病中的心力衰竭:第二版通用定义带来的变化

Heart failure in chronic kidney disease: what the second universal definition changes.
PubMed 文献 · Nephrol Dial Transplant · 2026-10-05

本文解读2026年第二版心力衰竭通用定义在肾脏病领域的应用。该定义将心衰视为由症状体征、心脏结构或功能异常客观证据及动态疾病轨迹构成的综合征,强调在CKD和透析人群中需整合纵向症状、淤血、影像、生物标志物、容量状态及治疗反应来诊断,避免仅依赖LVEF或住院编码。

要点

  • CKD中呼吸困难、水肿、生物标志物升高和心脏结构异常常见但单独不具诊断性,需综合纵向多参数判断。
  • 透析患者因液体 shifts、血管通路血流、心肌顿抑和生物标志物清除改变使表型复杂。
  • 新框架支持早期预防、区分心衰恶化与失代偿、病因导向评估而非依赖LVEF。

核心结论

  • 第二版通用心衰定义可为肾脏病提供连贯术语,但其价值取决于避免诊断膨胀、在CKD试验中标准化心衰表型及在反复淤血和肾衰竭前整合心肾照护。

研究设计与样本

  • 本文为综述,在肾脏病背景下解读2026年第二版心力衰竭通用定义共识。

主要发现

  • CKD中呼吸困难、水肿、生物标志物升高和心脏结构异常频繁出现但单独不具诊断性。
  • 诊断需整合纵向症状、淤血、影像、生物标志物、容量状态及治疗反应。
  • 透析中液体 shifts、通路血流、心肌顿抑和生物标志物清除改变使表型复杂。
  • 新框架支持早期预防、区分心衰恶化与失代偿及病因导向评估。

临床怎么用

  • 在CKD和透析患者中避免仅凭LVEF或行政住院编码诊断心衰。
  • 整合纵向症状、淤血、影像、生物标志物、容量状态和治疗反应进行心衰表型。
  • 区分可逆性淤血与慢性心脏病以改善共享决策并设定现实治疗目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure and chronic kidney disease (CKD) are biologically entwined and clinically difficult to disentangle. The 2026 Second Universal Definition of Heart Failure reframes heart failure as a syndrome defined by symptoms and signs, objective evidence of structural or functional cardiac abnormality, and a dynamic disease trajectory. Its implications for CKD and dialysis require focused consideration. SCOPE: This review interprets the consensus in a nephrology context. It considers the move beyond rigid left ventricular ejection fraction (LVEF) thresholds; the recognition of at-risk and pre-heart-failure stages; causal classification; trajectories of improvement, remission, recovery, worsening, and decompensation; and the effects of social and geographic context. KEY OBSERVATIONS: In CKD, dyspnoea, oedema, biomarker elevation, and cardiac structural abnormalities are frequent but individually non-diagnostic. Diagnosis requires integration of longitudinal symptoms, congestion, imaging, biomarkers, volume status, and response to treatment. The new framework is especially pertinent to dialysis, where fluid shifts, access flow, myocardial stunning, and altered biomarker clearance complicate phenotyping. It also supports earlier prevention, careful distinction between worsening and decompensated heart failure, and aetiology-directed evaluation rather than reliance on LVEF or administrative hospitalisation codes. INTERPRETATION: The consensus offers nephrology a coherent vocabulary. Its value will depend on avoiding diagnostic inflation, standardising heart-failure phenotyping in CKD trials, and integrating cardiac and kidney care before recurrent congestion and kidney failure occur. It should also improve shared decision making by separating potentially reversible congestion from chronic cardiac disease, and by defining realistic therapeutic aims: prevention, symptom relief, fewer decompensations, preservation of function, and longer survival.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Zoccali C, Mallamaci F. Heart failure in chronic kidney disease: what the second universal definition changes. Nephrol Dial Transplant. 2026. PMID: 42832082. doi:10.1093/ndt/gfag227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。